Efficacy of vedolizumab in granulomatous cheilitis refractory to TNFα inhibitors

Alexandre Gueutier, Sophie Leducq, Aline Joly, Laurence Picon, Loic Vaillant, Mahtab Samimi

Open source

DOI
10.1111/ijd.14638
Published
2019-09-09
Container
International Journal of Dermatology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ijd.14638,
  title = {Efficacy of vedolizumab in granulomatous cheilitis refractory to TNFα inhibitors},
  author = {Alexandre Gueutier and Sophie Leducq and Aline Joly and Laurence Picon and Loic Vaillant and Mahtab Samimi},
  year = {2019},
  journal = {International Journal of Dermatology},
  doi = {10.1111/ijd.14638},
  url = {https://doi.org/10.1111/ijd.14638}
}

RIS

TY  - JOUR
TI  - Efficacy of vedolizumab in granulomatous cheilitis refractory to TNFα inhibitors
AU  - Alexandre Gueutier
AU  - Sophie Leducq
AU  - Aline Joly
AU  - Laurence Picon
AU  - Loic Vaillant
AU  - Mahtab Samimi
PY  - 2019
JO  - International Journal of Dermatology
DO  - 10.1111/ijd.14638
UR  - https://doi.org/10.1111/ijd.14638
ER  - 

APA

Gueutier, A., Leducq, S., Joly, A., Picon, L., Vaillant, L., & Samimi, M. (2019). Efficacy of vedolizumab in granulomatous cheilitis refractory to TNFα inhibitors. International Journal of Dermatology. https://doi.org/10.1111/ijd.14638

Source records